CN1299723C - Medicine for treating rhomboembolia type angiitis - Google Patents
Medicine for treating rhomboembolia type angiitis Download PDFInfo
- Publication number
- CN1299723C CN1299723C CNB2005100176777A CN200510017677A CN1299723C CN 1299723 C CN1299723 C CN 1299723C CN B2005100176777 A CNB2005100176777 A CN B2005100176777A CN 200510017677 A CN200510017677 A CN 200510017677A CN 1299723 C CN1299723 C CN 1299723C
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- portions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 120
- 229940079593 drug Drugs 0.000 title description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 25
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 23
- 235000008434 ginseng Nutrition 0.000 claims abstract description 23
- 208000033386 Buerger disease Diseases 0.000 claims description 53
- 206010043540 Thromboangiitis obliterans Diseases 0.000 claims description 53
- 241000628997 Flos Species 0.000 claims description 23
- 241000208340 Araliaceae Species 0.000 claims description 22
- 241000245240 Lonicera Species 0.000 claims description 20
- 241000545442 Radix Species 0.000 claims description 20
- 241001530126 Scrophularia Species 0.000 claims description 20
- 239000005445 natural material Substances 0.000 claims description 18
- 239000002552 dosage form Substances 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 16
- 238000002360 preparation method Methods 0.000 abstract description 16
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 208000007536 Thrombosis Diseases 0.000 abstract description 6
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000001338 necrotic effect Effects 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 2
- 241000405414 Rehmannia Species 0.000 abstract 2
- 230000004087 circulation Effects 0.000 abstract 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 210000004392 genitalia Anatomy 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 17
- 210000003371 toe Anatomy 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 206010028851 Necrosis Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000017074 necrotic cell death Effects 0.000 description 10
- 210000002683 foot Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 210000003141 lower extremity Anatomy 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 4
- 238000002266 amputation Methods 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 206010017711 Gangrene Diseases 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 3
- 241000208125 Nicotiana Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000010009 beating Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 206010002027 Amyotrophy Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000283956 Manis Species 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010047115 Vasculitis Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 206010000598 Acrodynia Diseases 0.000 description 1
- 231100000455 Acrodynia Toxicity 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 241001489978 Eupolyphaga Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016970 Foot fracture Diseases 0.000 description 1
- 241001251068 Formica fusca Species 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 231100000429 cutaneous necrosis Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- -1 ethanol extraction Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000009212 ren-shen-yang-rong-tang Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000010124 zhibai dihuang Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine taking natural Chinese medicinal materials as raw materials, particularly to a medicine for treating thrombus occlusion type angitis. The medicine takes a portion by weight as a unit, and comprises 10 to 30 portions of angelica, 5 to 15 portions of cassia twigs, 30 to 60 portions of astragalus roots, 10 to 30 portions of ginseng, 10 to 20 portions of prepared rhizome of rehmannia, 30 to 60 portions of honeysuckle, 20 to 50 portions of figwort and 10 to 20 portions of achyranthes. The angelica and the prepared rhizome of rehmannia with the portions by weight are frozen to dryness; the other components are dried; all of the components are sieved for 100 meshes after pulverized to make into the medicine for treating thrombus occlusion type angitis of the present invention. The present invention takes the Chinese traditional Chinese medicine theory as base, and combines clinical practices of many years, the medicine for treating thrombus occlusion type angitis is refined by pure traditional Chinese medicines filtered from Chinese medicine treasure houses, and the pure traditional Chinese medicines have the functions of promoting blood circulation to eliminate gore, warming channels for dispelling cold, benefiting circulation and nourishing blood, restoring male genitals, promoting circulation, eliminating necrotic tissue and promoting muscles. The present invention has the advantages of reasonable recipe, low cost, simple preparation and obvious clinic curative effect, is suitable for various thrombus occlusion type angitis patients, and is capable of obviously enhancing human body immunity.
Description
One. technical field: the present invention relates to a kind of is the medicine of raw material with the natural Chinese medicine, particularly relates to a kind of medicine for the treatment of thromboangiitis obliterans.
Two. background technology: thromboangiitis obliterans is a kind of chronic general vascular disorder, pathological changes involve extremity in, small-sized arteriovenous is seen so that lower limb more more, motherland's medical science thinks that primary disease is sick mainly to be because feelings will internal injury admittedly, kidney liver deficiency, cold-damp is subjected to outward, so that cold-damp cohesion meridians, the numbness plug is obstructed, and vim and vigour running is not smooth, and lumen of vessels takes place inaccessible, the tube wall fibrosis, cause the local organization ischemia, last necrosis causes acral coming off, and cold stimulation is the key factor that primary disease takes place, extremity are the end of all sun, get yang-energy and temperature, the place is cold for a long time, and the cold-evil compels outward, yang-energy can not reach in limb end, cause the cold-evil to attack channels deeply, QI and blood is not smooth, and blood is met cold coagulation, it is obstructed to be retarded by silt, stagnation of QI and blood may bring about pain, with the passing of time, limbs are just become homeless foster, cause gangrene, thereby claim " necrosis disease " again; In addition, the generation of primary disease is also relevant with factors such as long-term smoking, wounds, and under the long-time stimulus of these factors, central nervous system's adjusting is hindered, the autonomic nerve system hormonal system functional disorder (as suprarenalism) of unifying, can make slow blood flow, medium and small continuous vessel spasm, blood vessel wall malnutrition, thrombosis and lumen of vessels obturation, local organization ischemia, necrosis, come off, secondary infection makes that the pain increased.
At present, this disease still there is not satisfied treatment measure both at home and abroad, doctor trained in Western medicine adopts the treatment of blood vessel dilating medicine more, and this type of therapy has certain curative effect to I, II phase patient, but to III phase severe infections patient, adopt potent analgesic to cooperate antibiotic therapy, the person of failing to respond to any medical treatment or end-stage patients' extremity gangrene adopts the amputation that cuts toe or Different Plane, and this operative therapy patient not only will bear huge misery, from then on the more important thing is becomes deformity, has increased burden for family and society.The traditional Chinese medical science Therapeutic Method that adopt based on activating blood circulation to dissipate blood stasis more, as TAOREN SIWU TANG, SIMIAOYONGAN TANG, RENSHEN YANGRONG TANG, attached osmanthus eight flavor balls, ZHIBAI DIHUANG WAN etc., according to the treatment of state of an illness plus-minus, the effect of this Therapeutic Method obviously is better than western medical treatment, but because the complexity of this sick pertinacious disease cause of disease, drug component and consumption unreasonable causes effect still not satisfactory.
Chinese invention patent CN1181868C, application number is 02135295.X, denomination of invention is: in " Chinese medicine preparation of treatment thromboangiitis obliterans ", a kind of Chinese medicine for the treatment of the chronic occlusion inflammation of peripheral vessels is disclosed, it is with Formica fusca, the big gun Squama Manis, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae, Rhizoma Curcumae, Radix Angelicae Sinensis, Fructus Forsythiae, Radix Ilicis Pubescentis, Rhizoma Smilacis Glabrae, 36 kinds of Chinese medicines such as the Rhizoma Anemarrhenae are raw material, according to the characteristic of medicine through pulverizing, soak, decoct, filter, concentrate, ethanol extraction, mix, technologies such as porphyrize are made, it is introduced that this curative effect of medication is excellent, but this medicine compatibility is more, sometimes be difficult to assort, and complicated process of preparation gives to apply to make troubles; Chinese invention patent CN1132608C, application number is 01113997.8, denomination of invention is: disclose a kind of Chinese medicine for the treatment of thromboangiitis obliterans in " a kind of Chinese medicine for the treatment of thromboangiitis obliterans ", it is by Radix Angelicae Sinensis, the Radix Paeoniae Alba, Semen Persicae, Flos Carthami, Radix Scrophulariae, Radix Salviae Miltiorrhizae, Flos Lonicerae, Fructus Forsythiae, Radix Ilicis Pubescentis, Rhizoma Smilacis Glabrae, Squama Manis, Hirudo, Scolopendra, 21 kinds of principal agents such as Eupolyphaga Seu Steleophaga and Rhizoma Coptidis, Cortex Phellodendri, Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi, 5 kinds of attached medicines of Rhizoma Zingiberis are pulverize together, incapsulate or become decoction to form with decocting, it is more that this Chinese medicine has compatibility equally, the shortcoming that is difficult to assort, and cost is higher, for vast rural area and remote mountain area patient, there is a kind of serious financial burden.Chinese invention patent CN1023968C, application number is 90106330.4, denomination of invention is: disclose a kind of preparation method for the treatment of the smoke of vasculitis disease in " preparation method of angitis fumigant ", but smoke has shortcomings such as complex manufacturing technology, use inconvenience.So, people still crave for have a kind of cost low, be convenient to take and medicine that therapeutic effect is better treated thromboangiitis obliterans comes out.
Three. summary of the invention:
The objective of the invention is: the medicine that a kind of advantages of simple of filling a prescription, clinical effectiveness treatment thromboangiitis obliterans remarkable, with low cost is provided.
Technical scheme of the present invention is: a kind of medicine for the treatment of thromboangiitis obliterans, with the weight portion is unit, this medicine is made up of following natural material medicine: 10～30 parts of Radix Angelicae Sinensis, 5～15 parts of Ramulus Cinnamomi, 30～60 parts of the Radixs Astragali, 10～30 parts of Radix Ginsengs, 10～20 parts in Radix Rehmanniae Preparata, 30～60 parts of Flos Loniceraes, 20～50 parts of Radix Scrophulariaes, 10～20 parts of Radix Achyranthis Bidentataes.
The optimum ratio of the medicine of treatment thromboangiitis obliterans recited above is: 30 parts of Radix Angelicae Sinensis, 15 parts of Ramulus Cinnamomi, 30 parts of the Radixs Astragali, 20 parts of Radix Ginsengs, 20 parts in Radix Rehmanniae Preparata, 30 parts of Flos Loniceraes, 30 parts of Radix Scrophulariaes, 18 parts of Radix Achyranthis Bidentataes.
A kind of medicine for the treatment of thromboangiitis obliterans, with the weight portion is unit, this medicine is made up of following natural material medicine: 15～25 parts of Radix Angelicae Sinensis, 6～10 parts of Ramulus Cinnamomi, 40～50 parts of the Radixs Astragali, 15～25 parts of Radix Ginsengs, 10～20 parts in Radix Rehmanniae Preparata, 40～50 parts of Flos Loniceraes, 30～40 parts of Radix Scrophulariaes, 10～20 parts of Radix Achyranthis Bidentataes.
The optimum ratio of the medicine of treatment thromboangiitis obliterans recited above is: 20 parts of Radix Angelicae Sinensis, 10 parts of Ramulus Cinnamomi, 40 parts of the Radixs Astragali, 15 parts of Radix Ginsengs, 15 parts in Radix Rehmanniae Preparata, 45 parts of Flos Loniceraes, 30 parts of Radix Scrophulariaes, 10 parts of Radix Achyranthis Bidentataes.
With Radix Angelicae Sinensis, the Radix Rehmanniae Preparata lyophilizing in the medicine material medicine of any treatment thromboangiitis obliterans recited above, remaining each component oven dry after grinding together, is crossed 100 mesh sieves, makes required pharmaceutical dosage form.
Described pharmaceutical dosage form is a powder, or is tablet, or is pill, or is granule, or is capsule.
Positive beneficial effect of the present invention is:
1. the medicine of treatment thromboangiitis obliterans of the present invention, based on motherland's Chinese medicine and pharmacy theory, in conjunction with clinical practice for many years, from motherland medicine treasure-house, filter out have heat-clearing and toxic substances removing, YIN nourishing removing heat from blood, activating blood circulation and dissipating blood stasis, dispelling cold by warming the meridian, benefiting qi and nourishing blood, recuperating depleted YANG are promoted blood circulation, the pure purification of tcm of removing the necrotic tissue and promoting granulation forms, effect with blood vessel dilating, thrombus, blood circulation promoting, the local blood supply state of change, and residence is attacked in mending, attacking and just not to be hindered, to mend and do not stop up, and can obviously improve the immunity of human body.
2. the medicine of treatment thromboangiitis obliterans of the present invention is a Chinese medicine preparation, need not decoct, can carry, and taking convenience, general patients with mild need not be in hospital, and can reduce patient's spending significantly, reduces medical expense.
3. the medicine of treatment thromboangiitis obliterans of the present invention, prescription is reasonable, and cost is low, and processing is simple, and clinical efficacy is obvious, is applicable to the thromboangiitis obliterans patient that each phase is dissimilar.
4. the medicine of treatment thromboangiitis obliterans of the present invention, when the patient with severe symptoms of treatment second phase, three phases, other ancillary drug that adds the inventor cooperates the acupoint injection therapy treatment, effective percentage reaches 100%, especially to the patient of obstinate disease, can cure without amputation, be subjected to the favorable comment of patient and family numbers of patients deeply.
In the medicine of treatment thromboangiitis obliterans of the present invention: the sweet temperature of Radix Angelicae Sinensis toil, benefiting blood and regulating blood circulation is the key medicine of temperature compensation liver blood; The hot temperature of Ramulus Cinnamomi, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI, the evil logical blood of cold relieving is capable, and two medicines share, and take a tonic or nourishing food to build up one's health with Wen Tong and execute, and can receive an effect of mending two and three warm four-ways, and pretending is that monarch drug uses.The sweet temperature of the Radix Astragali, strongly invigorating primordial QI, reinforcing body resistance, eliminating evil going out associated with useful temperature sun, the outer power of driving of enhancing with Ramulus Cinnamomi warming the meridian for promoting the flow of YANG QI, the diffusing exopathogen of dispelling; The Radix Ginseng sweet in the mouth, invigorating primordial QI is slaked thirst and help produce saliva; Radix Rehmanniae Preparata tepor, but YIN nourishing removing heat from blood, the kidney invigorating is quenched one's thirst, and three medicines are all ministerial drug." necrosis " disease, non-one day of onset and sending out, exopathogenic factor has the cold-evil to cause, and is interior because give birth in the fire-toxin, pyretic toxicity is pented up, and QI and blood is retarded by silt, and the venation obturation is obstructed, and Flos Lonicerae, Radix Scrophulariae have the effect of heat-clearing and toxic substances removing, two medicines share, and both clearing heat in QI system divided pathogenic heat, separate cold-damp heat-transformation poison again, pretend to be the adjuvant drug use.Radix Achyranthis Bidentatae is gentle, but invigorating the liver and kidney, bone and muscle strengthening, and eliminating blood stasis and inducing menstruation, conducting blood to flow downwards are with being messenger drug.
The medicine of treatment thromboangiitis obliterans of the present invention, mechanism according to the traditional Chinese medical science " stagnation of QI is stasis then; the capable then blood of gas is capable; the capable then sick spontaneous recovery of blood ", reach the purpose of repercussive with benefiting vital QI and blood, " necrosis " patient again, the endogenous cause of ill heart, liver, spleen, kidney four is dirty all empty, and the exopathogenic factor cold-evil is strongly fragrant for a long time, accumulates and heat-transformation or surfeit greasy and surfeit flavour, pungently process rich and cause life fire-toxin in, if only use Radix Angelicae Sinensis, Ramulus Cinnamomi, the Radix Astragali, Radix Ginseng probably has impairment of YIN dryness-transformation anxiety, admittedly add Radix Rehmanniae Preparata, to make the scorching of the Ramulus Cinnamomi and the Radix Astragali, the kidney invigorating void again Kidney-Yin, monarch, minister, assistant, make and share, the effect of the dehumidifying of invigorating blood circulation is not only arranged, and detoxifcation arranged, removing heat from blood is fruit, it is applicable to the thromboangiitis obliterans patient that each phase is dissimilar, and especially the patient of obstinate disease can cure without amputation, being subjected to patient's favorable comment deeply, is the medicine of present comparatively ideal treatment thromboangiitis obliterans.
5. the clinical efficacy situation is added up:
Case is selected: the hospital at inventor place accepts patient's 2997 examples of the thromboangiitis obliterans in more than 100 county of 19 provinces, cities and autonomous regions in the whole nation so far altogether for medical treatment from the eighties in last century, male's 2398 examples wherein, women's 599 examples, male, women patient's ratio is about 4: 1, and patient 1798 examples of age between 20～45 years old account for 60%, patient 300 examples of age between 45～65 years old, account for 10%, the patient of other age bracket accounts for 30%, and the most of patients course of disease is more than half a year.
Diagnostic classification:, generally the patient is divided into three kinds according to medical history, symptom, sign:
First phase claims ischemic stage again, and side lower limb are afraid of cold, and acra is numb, whiteness of skin, and amyotrophy, the shank of walking expands and aches, knots;
Second phase claims the dysfunction phase again, and the lower limb acrodynia continues, and intermittent claudication is obvious, and toes continue to turn cold, and palor is livid purple;
Three phases claimed the downright bad phase again, and local organization is seriously downright bad, i.e. " gangrene ", dorsal artery of foot is beaten and is weakened or disappear, severe pain unbearably, slough obviously comes off.
Above-mentioned 2997 routine patients, first phase patient 1939 examples, the second stage of patient's 875 examples, three phase patients, 183 examples.
Therapeutic Method: to being diagnosed as the patient of thromboangiitis obliterans, give the drug administration of treatment thromboangiitis obliterans of the present invention, twice on the one, one time 6～12 gram, warm boiled water, 30 days is a course of treatment, generally needs to treat 1～6 course of treatment, effect preferably be can reach, suffering, peppery, greasy food and Folium Camelliae sinensis and tobacco and wine avoided at period in a medicine.
Curative effect judging standard:
Recovery from illness: symptom thoroughly disappears, no sequel;
Produce effects: symptom disappears substantially, and lame slightly after the treatment, other is as the normal person;
Effectively: pain and other symptom are obviously alleviated, and just can fully recover after adding inventor's other medicines auxiliary treatment.
Therapeutic outcome:
| Clinical manifestation | Recovery from illness | Produce effects | Effectively | ||||
| Symptom | Total number of persons | Number | Ratio | Number | Ratio | Number | Ratio |
| First phase | 1939 | 1642 | 84.68％ | 275 | 14.08％ | 22 | 1.13％ |
| Second phase | 875 | 697 | 79.66％ | 138 | 15.77％ | 40 | 4.57％ |
| Three phases | 183 | 124 | 67.76％ | 28 | 15.30％ | 31 | 16.94％ |
| Amount to | 2997 | 2463 | 82.18％ | 441 | 14.71％ | 93 | 3.11％ |
By above-mentioned clinical efficacy situation statistics as can be known: the medicine of treatment thromboangiitis obliterans of the present invention has very notable therapeutic effect.
Model case:
1. Liu, man, 38 years old, people from Huangchuan County, Henan, shop assistant, severe winter patient way walking far away in 1971, toes are endured cold, and sensation left side foot is little painful then, and the heavy summer in winter is light, do not draw attention as yet, to the autumn in 1980 because of paddling twice, pain increases the weight of, whenever cold weather then severe pain unbearably, though once still do not produce effects with the Drug therapy of tiger-bone medicated wine wind-damp dispelling and so on, heavier to winter nineteen eighty-two pain, the purple black flowing water of Ipsilateral toes, the shank atrophy that attenuates is walked with difficulty, in the hospitalize that came the inventor place May 6 then, it is thin to see patient's yellow complexion, red tongue is red, and six kinds of pulses is heavy fine puckery, falls YANG pulse disappearances (left side) the popliteal of beating and moves A and beat also fine, suffer from toe and be black, little swollen, sending out of laying one's hand on is cool, a small amount of sewage is oozed on the first limit, the homonymy skin of leg is grey thick, and fine hair comes off, amyotrophy, Western medicine diagnose is: thromboangiitis obliterans, tcm diagnosis is: necrosis (yang deficiency cold-condensing type).The medicine of treatment thromboangiitis obliterans of the present invention is taken in suggestion, twice, one time on the one 8 gram, and warm boiled water is after the course of treatment, trouble toe corruption takes off tissue regeneration promoting, and muscle is ruddy, and wound will be healed, continuous again medicine of obeying a course of treatment, spirit is good, and symptom disappears entirely, and freedom of movement returns working unit.
The week certain, man, 42 years old, Liuzhou city government functionary, the hospitalize that on March 14th, 1988 was come the inventor place, patient master states: left foot send out cool be afraid of to freeze, numb, sharp ache, night more very, must injection dolantin pain relieving, walking is walked lamely, because of pain and emotion gloomy, coronary heart disease is shown effect often, have previously surplus the smoking history 20 year, biped cold injury and left side foot fracture medical history arranged, and have a heart disease, old lower wall infraction.See patient's left foot skin and be kermesinus, skin temperature is ice-cold, and toes skin follows the string, and fine hair disappears, the first other skin ulceration wound surface of seeing 0.6 centimetre of a diameter in the 4th toe outside, a left side has a little faint yellow transudate, and the YANG pulse disappearance of beating is fallen on a left side, walking is walked lamely, and need lean on and turn, red tongue.White and thin fur, stringy pulse, lower extremity blood flow figure, instep, left side and each toe-end blood flow of the tip figure all are irregular f wave, and wave amplitude does not disappear; This case Western medicine diagnose is: thromboangiitis obliterans, tcm diagnosis is: deficiency of YIN cold coagulation blood vessels, the YIN-cold type necrosis due to venation numbness resistance is obstructed (deficiency of YIN tremble with fear Sheng type).The medicine of treatment thromboangiitis obliterans of the present invention is taken in suggestion, twice, one time on the one 10 gram, warm boiled water, after half course of treatment, left foot skin alternating temperature, colour of skin flushing, pain relief, coronary heart disease, angina pectoris are not reaccessed yet, after two courses of treatment, walking is normal, and left skin of foot is warm, does not have uncomfortable symptom, recovery from illness is left hospital, and follows up a case by regular visits to not recurrence in 5 years.
3. Lee, man, 20 years old, the peasant, slope, Guangshan County, Henan river village people, come to go to a doctor June 11 nineteen ninety-five, body is looked into: the biped toe palm is downright bad as charcoal, light night pain day is heavy, and left hallux toe, inferior skin of toe fester and sequestrum occurs, vola about 13 * 18cm that festers, ulcer is extended down to the about 6 * 5cm in the outside, instep, other cutaneous necrosis of the vola back of the body, the about 6 * 5cm of right vola ulcer, biped ulceration place sewage is smelly dirty; Pale complexion, the thin Mental fatigue of shape, irritated irritability, inappetence, dark tongue quality, thin fur, pulse condition is counted accurately; This case Western medicine diagnose is: thromboangiitis obliterans, tcm diagnosis is: necrosis (YIN-cold poison Sheng type).Take the medicine of treatment thromboangiitis obliterans of the present invention, surgery is treated with inventor's other medicines, behind the two weeks, it is red that the wound color is changeed, and pain obviously alleviates, and slough begins to come off, diet increases, and spirit takes a turn for the better, after two courses of treatment, except that downright bad toes came off, other wound surface all healed, and pain disappears, can walk, add and consolidate curative effect, drug withdrawal after half a year four courses of treatment, so far follow up a case by regular visits to, all are normal.
4. high certain, the man, 38 years old, the peasant, Huang Po people from outskirts of a town, Hubei, on February 26th, 1996 went to a doctor, patient master states: necrosis medical history 10 years, once repeatedly advised the two lower limb of its amputation, patient's refusal at several families large hospital.It is thin to see the empty shape of body, and shallow complexion, severe pain are gone down on one's knees and embraced foot unbearably, and it is without cease to moan, and cardiopalmus is insomnia, and body of the tongue is light red, white and thin fur, deep-rolling pulse; Looking into two ice-cold ， popliteal of lower limb, shin arteries and veins can not stereognosis, and both feet are not except that the female toe in a left side comes off, all the other come off entirely, and the routed pus of wound is green, and is dripping more than, smelly dirty unpleasant, this case Western medicine diagnose is: thromboangiitis obliterans (downright bad phase of three phases), tcm diagnosis is: necrosis (yang deficiency of spleen and stomache).Take two courses of treatment of medicine of treatment thromboangiitis obliterans of the present invention, newly granulating grows, and the wound surface color and luster takes a turn for the better, and the drug withdrawal of fully recovering after half a year is followed up a case by regular visits to so far, all normal nothing recurrences.
5. Zhang, the man, 38 years old, the cadre, Xiangtan County, Hunan innings cadre, patient's medical history: suffer from vasculitis several years, because of participating in field labour, bump broken toes accidentally and cause, the trouble toe festers and suppurates, and pain is serious, lies awake all night; Look into patient left side purple of standard purity, the rotten muscle of meat loses, and falls YANG pulse disappearances of beating, and three-toed festers to middle joint, rotten exposed bone, and it is ice-cold to suffer from foot, and pulse condition sinks carefully unable, the tongue fur BOHUANG; The medicine of treatment thromboangiitis obliterans of the present invention is taken in suggestion, uses the inventor's other drug in addition, after half course of treatment, pain subtracts, and ulcer flowing water also takes a turn for the better, and spiritual appetite is good, after three courses of treatment, rotten bone takes off, wound healing, walking must crutch, spirit, diet, sleep are as usual, continue to take two courses of treatment, recovery from illness, symptom disappears entirely, does not have recurrence so far.
Four. the specific embodiment:
Embodiment one: a kind of medicine for the treatment of thromboangiitis obliterans, containing with the weight portion is the following natural material medicine of unit: 10 parts of Radix Angelicae Sinensis, 5 parts of Ramulus Cinnamomi, 30 parts of the Radixs Astragali, 10 parts of Radix Ginsengs, 10 parts in Radix Rehmanniae Preparata, 30 parts of Flos Loniceraes, 20 parts of Radix Scrophulariaes, 10 parts of Radix Achyranthis Bidentataes, Radix Angelicae Sinensis, Radix Rehmanniae Preparata lyophilizing with described weight portion, remaining each component oven dry after grinding together, is crossed 100 mesh sieves, make required pharmaceutical dosage form, patient one time 6～12 gram, ante cibum warm boiled water, twice of every day, 30 days is a course of treatment, avoids suffering, peppery, greasy food and Folium Camelliae sinensis and tobacco and wine at period in a medicine.
Embodiment two: the preparation of present embodiment medicine and the method for taking are with embodiment one, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 30 parts of Radix Angelicae Sinensis, 15 parts of Ramulus Cinnamomi, 60 parts of the Radixs Astragali, 30 parts of Radix Ginsengs, 20 parts in Radix Rehmanniae Preparata, 60 parts of Flos Loniceraes, 50 parts of Radix Scrophulariaes, 20 parts of Radix Achyranthis Bidentataes.
Embodiment three: the preparation of present embodiment medicine and the method for taking are with embodiment one, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 30 parts of Radix Angelicae Sinensis, 15 parts of Ramulus Cinnamomi, 30 parts of the Radixs Astragali, 20 parts of Radix Ginsengs, 20 parts in Radix Rehmanniae Preparata, 30 parts of Flos Loniceraes, 30 parts of Radix Scrophulariaes, 18 parts of Radix Achyranthis Bidentataes.
Embodiment four: the preparation of present embodiment medicine and the method for taking are with embodiment one, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 20 parts of Radix Angelicae Sinensis, 10 parts of Ramulus Cinnamomi, 40 parts of the Radixs Astragali, 20 parts of Radix Ginsengs, 15 parts in Radix Rehmanniae Preparata, 50 parts of Flos Loniceraes, 40 parts of Radix Scrophulariaes, 15 parts of Radix Achyranthis Bidentataes.
Embodiment five: the preparation of present embodiment medicine and the method for taking are with embodiment one, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 15 parts of Radix Angelicae Sinensis, 8 parts of Ramulus Cinnamomi, 50 parts of the Radixs Astragali, 15 parts of Radix Ginsengs, 13 parts in Radix Rehmanniae Preparata, 45 parts of Flos Loniceraes, 30 parts of Radix Scrophulariaes, 12 parts of Radix Achyranthis Bidentataes.
Embodiment six: the preparation of present embodiment medicine and the method for taking are with embodiment one, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 25 parts of Radix Angelicae Sinensis, 14 parts of Ramulus Cinnamomi, 45 parts of the Radixs Astragali, 25 parts of Radix Ginsengs, 17 parts in Radix Rehmanniae Preparata, 55 parts of Flos Loniceraes, 35 parts of Radix Scrophulariaes, 19 parts of Radix Achyranthis Bidentataes.
Embodiment seven: a kind of medicine for the treatment of thromboangiitis obliterans, containing with the weight portion is the following natural material medicine of unit: 15 parts of Radix Angelicae Sinensis, 6 parts of Ramulus Cinnamomi, 40 parts of the Radixs Astragali, 15 parts of Radix Ginsengs, 10 parts in Radix Rehmanniae Preparata, 40 parts of Flos Loniceraes, 30 parts of Radix Scrophulariaes, 10 parts of Radix Achyranthis Bidentataes, Radix Angelicae Sinensis, Radix Rehmanniae Preparata lyophilizing with described weight portion, remaining each component oven dry after grinding together, is crossed 100 mesh sieves, make required pharmaceutical dosage form, patient one time 6～12 gram, ante cibum warm boiled water, twice of every day, 30 days is a course of treatment, avoids suffering, peppery, greasy food and Folium Camelliae sinensis and tobacco and wine at period in a medicine.
Embodiment eight: the preparation of present embodiment medicine and the method for taking are with embodiment seven, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 25 parts of Radix Angelicae Sinensis, 10 parts of Ramulus Cinnamomi, 50 parts of the Radixs Astragali, 25 parts of Radix Ginsengs, 20 parts in Radix Rehmanniae Preparata, 50 parts of Flos Loniceraes, 45 parts of Radix Scrophulariaes, 20 parts of Radix Achyranthis Bidentataes.
Embodiment nine: the preparation of present embodiment medicine and the method for taking are with embodiment seven, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 20 parts of Radix Angelicae Sinensis, 10 parts of Ramulus Cinnamomi, 40 parts of the Radixs Astragali, 15 parts of Radix Ginsengs, 15 parts in Radix Rehmanniae Preparata, 45 parts of Flos Loniceraes, 30 parts of Radix Scrophulariaes, 10 parts of Radix Achyranthis Bidentataes.
Embodiment ten: the preparation of present embodiment medicine and the method for taking are with embodiment seven, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 22 parts of Radix Angelicae Sinensis, 8 parts of Ramulus Cinnamomi, 45 parts of the Radixs Astragali, 20 parts of Radix Ginsengs, 17 parts in Radix Rehmanniae Preparata, 50 parts of Flos Loniceraes, 35 parts of Radix Scrophulariaes, 15 parts of Radix Achyranthis Bidentataes.
Embodiment 11: the preparation of present embodiment medicine and the method for taking are with embodiment seven, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 17 parts of Radix Angelicae Sinensis, 7 parts of Ramulus Cinnamomi, 43 parts of the Radixs Astragali, 19 parts of Radix Ginsengs, 14 parts in Radix Rehmanniae Preparata, 46 parts of Flos Loniceraes, 31 parts of Radix Scrophulariaes, 12 parts of Radix Achyranthis Bidentataes.
Embodiment 12: the preparation of present embodiment medicine and the method for taking are with embodiment seven, something in common does not repeat, difference is: a kind of medicine for the treatment of thromboangiitis obliterans, and containing with the weight portion is the following natural material medicine of unit: 22 parts of Radix Angelicae Sinensis, 9 parts of Ramulus Cinnamomi, 49 parts of the Radixs Astragali, 21 parts of Radix Ginsengs, 19 parts in Radix Rehmanniae Preparata, 43 parts of Flos Loniceraes, 38 parts of Radix Scrophulariaes, 18 parts of Radix Achyranthis Bidentataes.
Claims (6)
1. medicine for the treatment of thromboangiitis obliterans, it is characterized in that with the weight portion being unit, this medicine is made up of following natural material medicine: 10～30 parts of Radix Angelicae Sinensis, 5～15 parts of Ramulus Cinnamomi, 30～60 parts of the Radixs Astragali, 10～30 parts of Radix Ginsengs, 10～20 parts in Radix Rehmanniae Preparata, 30～60 parts of Flos Loniceraes, 20～50 parts of Radix Scrophulariaes, 10～20 parts of Radix Achyranthis Bidentataes.
2. the medicine of treatment thromboangiitis obliterans according to claim 1 is characterized in that this medicine is made up of following natural material medicine: 30 parts of Radix Angelicae Sinensis, 15 parts of Ramulus Cinnamomi, 30 parts of the Radixs Astragali, 20 parts of Radix Ginsengs, 20 parts in Radix Rehmanniae Preparata, 30 parts of Flos Loniceraes, 30 parts of Radix Scrophulariaes, 18 parts of Radix Achyranthis Bidentataes.
3. medicine for the treatment of thromboangiitis obliterans, it is characterized in that with the weight portion being unit, this medicine is made up of following natural material medicine: 15～25 parts of Radix Angelicae Sinensis, 6～10 parts of Ramulus Cinnamomi, 40～50 parts of the Radixs Astragali, 15～25 parts of Radix Ginsengs, 10～20 parts in Radix Rehmanniae Preparata, 40～50 parts of Flos Loniceraes, 30～40 parts of Radix Scrophulariaes, 10～20 parts of Radix Achyranthis Bidentataes.
4. the medicine of treatment thromboangiitis obliterans according to claim 3 is characterized in that this medicine is made up of following natural material medicine: 20 parts of Radix Angelicae Sinensis, 10 parts of Ramulus Cinnamomi, 40 parts of the Radixs Astragali, 15 parts of Radix Ginsengs, 15 parts in Radix Rehmanniae Preparata, 45 parts of Flos Loniceraes, 30 parts of Radix Scrophulariaes, 10 parts of Radix Achyranthis Bidentataes.
5. according to the medicine of the described treatment thromboangiitis obliterans of the arbitrary claim of claim 1～4, it is characterized in that remaining each component oven dry after grinding together, is crossed 100 mesh sieves, makes required pharmaceutical dosage form with described Radix Angelicae Sinensis, Radix Rehmanniae Preparata lyophilizing.
6. the medicine of treatment thromboangiitis obliterans according to claim 5 is characterized in that described pharmaceutical dosage form is a powder, or is tablet, or be pill, or be granule, or is capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100176777A CN1299723C (en) | 2005-06-14 | 2005-06-14 | Medicine for treating rhomboembolia type angiitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100176777A CN1299723C (en) | 2005-06-14 | 2005-06-14 | Medicine for treating rhomboembolia type angiitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1724031A CN1724031A (en) | 2006-01-25 |
| CN1299723C true CN1299723C (en) | 2007-02-14 |
Family
ID=35923749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100176777A Expired - Fee Related CN1299723C (en) | 2005-06-14 | 2005-06-14 | Medicine for treating rhomboembolia type angiitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1299723C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600239A (en) * | 2012-04-27 | 2012-07-25 | 由丽萍 | Medicament for treating thromboangitis obliterans and preparation method thereof |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784335A (en) * | 2015-04-13 | 2015-07-22 | 梁晓 | Traditional Chinese medicine composition for treating qi-blood deficiency type thromboangiitis obliterans |
| CN107334862A (en) * | 2017-08-22 | 2017-11-10 | 徐州艾博生物科技有限公司 | Medicament for treating thromboangitis obliterans and preparation method thereof |
| CN113456734A (en) * | 2021-07-30 | 2021-10-01 | 张明之 | Formula for treating thromboangiitis obliterans |
| CN115137767B (en) * | 2022-08-09 | 2023-04-28 | 石家庄平安医院有限公司 | Traditional Chinese medicine composition for treating ischemic vasculitis caused by cold deficiency syndrome and preparation method thereof |
| CN116966232B (en) * | 2023-09-15 | 2024-06-04 | 上海市静安区中医医院 | Traditional Chinese medicine composition for treating phlegm-heat accumulated lung syndrome community-acquired pneumonia and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1171970A (en) * | 1997-06-26 | 1998-02-04 | 周淑琴 | Health-care wine with antisenility function |
| CN1326757A (en) * | 2000-06-01 | 2001-12-19 | 钱金舟 | Medicinal composition for curing protrusion of lumber intervertebral disc |
| CN1419934A (en) * | 2002-12-16 | 2003-05-28 | 阎位国 | Medicinal composition for treating brain apoplexy |
-
2005
- 2005-06-14 CN CNB2005100176777A patent/CN1299723C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1171970A (en) * | 1997-06-26 | 1998-02-04 | 周淑琴 | Health-care wine with antisenility function |
| CN1326757A (en) * | 2000-06-01 | 2001-12-19 | 钱金舟 | Medicinal composition for curing protrusion of lumber intervertebral disc |
| CN1419934A (en) * | 2002-12-16 | 2003-05-28 | 阎位国 | Medicinal composition for treating brain apoplexy |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600239A (en) * | 2012-04-27 | 2012-07-25 | 由丽萍 | Medicament for treating thromboangitis obliterans and preparation method thereof |
| CN102600239B (en) * | 2012-04-27 | 2014-02-05 | 由丽萍 | Medicament for treating thromboangitis obliterans and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1724031A (en) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100341545C (en) | Oral medicine for treating thromboangitis obliterans | |
| CN100493598C (en) | Oral Chinese traditional medicine composition for treating chronic enteritis | |
| CN101053632A (en) | Traditional Chinese medicine for treating thromboangitis obliterans | |
| CN1803187A (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN103505659A (en) | Chinese proprietary medicine for treating rheumatoid arthritis | |
| CN1299723C (en) | Medicine for treating rhomboembolia type angiitis | |
| CN103893380A (en) | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny | |
| CN1069527C (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN102343008B (en) | Chinese medicinal composition for treating prolapse of lumbar intervertebral disc | |
| CN104667035A (en) | Medicament for treating gout | |
| CN1788766A (en) | Oral Chinese traditional medicine for treating diabetes foot | |
| CN102512645B (en) | Traditional Chinese medicine composition for treating lumbago due to cold dampness | |
| CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN104258362A (en) | Traditional Chinese medicine preparation for treating peripheral neuritis | |
| CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN102940820A (en) | Traditional Chinese medicine composition for treating diarrhea | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN105106854A (en) | Traditional Chinese medicine preparation for treating lumbar spondylosis | |
| CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
| CN101380425A (en) | Arthrosis pill and production method thereof | |
| CN105079522A (en) | Medicine for treating chronic prostatitis | |
| CN105456538A (en) | Drug for treating osteoporosis | |
| CN105106913A (en) | Traditional Chinese medicine composition for treating spleen-kidney yang deficiency type chronic colitis | |
| CN1682998A (en) | Medicament for treating paraplegia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |